What is the extent of disparities in cancer clinical trials among low- and middle-income countries?
New research reveals that the number and complexity of cancer clinical trials since 2001 have…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma
The first-in-class YAP-TEAD inhibitor VT3989 continued to be well-tolerated and demonstrated notable initial antitumor activity, particularly…
New way to weaken cancer cells could supercharge prostate cancer treatment
A major international study has uncovered a new vulnerability in prostate cancer cells that could…
New research identifies a more accurate way of predicting which blood cancer patients will relapse early
Scientists have identified a more accurate way of predicting which patients with multiple myeloma, a…
Glue prevents complications after breast cancer surgery
Seroma and prolonged lymphorrhea are among the most frequent complications following axillary lymphadenectomy in patients…
ESMO 2025: Thymic health linked to immunotherapy response
The health of the thymus – a key part of the body’s immune system -…
ESMO 2025: Men with BRCA1 and BRCA2 gene mutations should get annual prostate cancer screening
Scientists at The Institute of Cancer Research, London, are calling for targeted screening after finding…
After cancer: Study explores caring-healing modalities for survivors
As cancer survivorship rises, many people living with or beyond cancer face lasting physical and…
A new treatment approach for patients with limited tamoxifen efficacy
Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch…
Study reveals how bacteria in tumours drive treatment resistance in cancer
Researchers have discovered a previously unknown mechanism that explains how bacteria can drive treatment resistance…